3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

Photo of Alex Sirois
By Alex Sirois Published
3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy

© Dimitrios Kambouris / Getty Images Entertainment via Getty Images

Warren Buffett built Berkshire Hathaway by paying reasonable prices for durable cash flows, and three of his current bets still trade below $30 a share. With Greg Abel sitting on a record cash pile, the sub-$30 aisle is where value hunters are scanning for the kind of brand-heavy, cash-generative franchises Omaha tends to favor when sentiment sours.

Here are five stocks under $30 that fit the Buffett template: three Berkshire already owns, plus two Abel could plausibly add to the book.

Kraft Heinz (NASDAQ: KHC)

Kraft Heinz (NASDAQ:KHC | KHC Price Prediction) owns Heinz, Philadelphia, Lunchables, and Primal Kitchen. Shares recently traded at $23.96, paying a 6.76% dividend yield at a forward multiple near 12. Q1 adjusted EPS hit $0.58 against a $0.5027 consensus, the fourth consecutive beat, while free cash flow jumped 58.9% to $766M. CEO Steve Cahillane’s $600M reinvestment plan anchors the turnaround case. The risk: organic net sales are guided down 1.5% to 3.5% on SNAP and private-label pressure. With analyst targets clustered near $23.87, the value here lives in the dividend.

Sirius XM (NASDAQ: SIRI)

Sirius XM (NASDAQ:SIRI) operates satellite radio and Pandora and just locked in an exclusive U.S. audio ad partnership covering YouTube’s roughly 255 million monthly listeners. Shares sit near $27.10, up 37.2% year to date, on a trailing P/E of 11 and forward P/E of 9. The dividend yields 4.04% at $0.27 quarterly. Q1 churn hit a record-low 1.5% and podcast revenue grew 37%, with full-year free cash flow guided to $1.35B. The bear note: self-pay subscribers are still shrinking. Wall Street targets average $28.08, leaving the cash return as the main draw.

Liberty Latin America (NASDAQ: LILA)

Liberty Latin America (NASDAQ:LILA) runs broadband and mobile networks across the Caribbean and Latin America under Flow, Liberty, and Más Móvil. Shares recently sat at $7.63, up 63.38% over the past year. Q1 operating income rose 13%, the company added 50,200 postpaid subscribers, and CEO Balan Nair announced plans to distribute $500M in 9% preferred stock. Berkshire still holds the position. The risk is real: net leverage sits at 4.5x and Hurricane Melissa weighed on Caribbean revenue. Analyst targets at $11.90 imply meaningful upside if recovery holds.

Nu Holdings (NYSE: NU)

Nu Holdings (NYSE:NU), Latin America’s largest digital bank, sits outside Berkshire’s current portfolio yet matches the profitable, scale-driven financial profile Abel has flagged interest in. It’s also formerly a Berkshire Hathaway holding. Shares trade near $13.80 at a trailing P/E of 23. Full-year revenue grew 42.06% to $15.77B, net income climbed 45.61% to $2.87B, and Q4 return on equity hit 33%. Nubank also secured conditional OCC approval for a U.S. national bank. Risks include Brazilian macro exposure and $4.20B in expected credit losses. Consensus target sits at $19.87, well above the current quote.

Pfizer (NYSE: PFE)

Pfizer (NYSE:PFE) is another non-Berkshire name that fits the Buffett-style screen Abel may inherit. Shares recently traded at $25.68, up 21.96% over the past year, pairing a 6.6% yield with a forward P/E of 9. The non-COVID portfolio grew 9% operationally in Q4, with Vyndaqel, Eliquis, and Abrysvo all posting double-digit gains. Q4 adjusted EPS came in at $0.66 versus a $0.57 consensus. Risks include a $1.5B loss-of-exclusivity headwind plus Most-Favored-Nation pricing uncertainty. Consensus target stands at $29.11.

A low share price by itself is never a thesis. Each of these names carries a specific risk that could undo the cheap headline multiple, from food-volume erosion to Brazilian macro to drug-pricing reform. Treat this list as a starting point for your own diligence, not a substitute for it.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

AXON Vol: 1,135,025
CDW
CDW Vol: 2,437,027
GEHC Vol: 8,107,093
IBM
IBM Vol: 16,078,074
CHTR Vol: 2,972,069

Top Losing Stocks

MU Vol: 59,509,070
ON Vol: 15,482,547
ENPH Vol: 6,285,705
LRCX Vol: 16,058,102
MCHP Vol: 18,300,666